Maeve 0.35 mg

Maeve 0.35 mg is a low-dose oral contraceptive tablet containing norethindrone. It is commonly used for birth control and menstrual cycle regulation. This medication is manufactured by Glenmark Pharmaceuticals Canada Inc.

Maeve 0.35 mg tablets are primarily used for birth control and managing menstrual irregularities. Norethindrone, the active ingredient, is a progestin that helps prevent ovulation and thicken cervical mucus. This medication is often prescribed for women seeking a reliable contraceptive option or those experiencing irregular menstrual cycles.

Common effects of Maeve 0.35 mg may include changes in menstrual bleeding patterns, such as lighter or more regular periods. Some users may experience mild side effects like headaches, nausea, or breast tenderness. These effects vary among individuals and typically subside as the body adjusts to the medication.

It is important to use Maeve 0.35 mg tablets as directed by a healthcare provider. Regular follow-ups are recommended to monitor any potential side effects. Women with a history of blood clots, liver disease, or certain cancers should consult their healthcare provider before starting this medication.

Maeve 0.35 mg may interact with other medications, including certain antibiotics, anticonvulsants, and HIV medications. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated while using this medication.